Jørgen

I, Jørgen Vestbo, nominated by Ministry of Environment and Food of Denmark, residing in Denmark, a member of the Medical and Chemicals Technical Options Committee declare as follows.

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am Professor of Respiratory Medicine at the University of Manchester, Manchester, UK. My responsibilities include research and teaching in respiratory medicine and management of patients; my area of focus is on chronic obstructive pulmonary disease (COPD) and inhaled therapies. I also see respiratory outpatients in a clinic in Copenhagen, Denmark.
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines.  I understand that this written agreement is a condition of my service.
4. My interests , and those of my personal partner and dependents, include the following:
   • Proprietary interests: I do not have proprietary interest in a substance, technology or process to be considered by TEAP or any of its TOCs or temporary subsidiary bodies (e.g. task forces).
   • Financial interests: I do not have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work.
   • Employment, consultancy, directorship or other positions:
     I have received honoraria from pharmaceutical companies (AstraZeneca, Boehringer-Ingelheim, Chiesi, GSK, Novartis and Teva) for advising and presenting. All work is being invoiced through a Danish tax registered one-man company, Vestbo medical, VAT Reg No 21215430.
     My son, Jakob Vestbo, is a Key account manager of Chiesi in Denmark.
     My wife, Inge Vestbo, worked from 1985 to 2009 in the pharmaceutical industry in Denmark and the UK.
     Government advice and other policy development: I am Chair of the Advocacy Council of the European Respiratory Society.
   • Paid research activities, fellowships or grants: I have previously held grants from GSK and together with a junior researcher in my group (Alexander Mathioudakis) I hold a grant from Boehringer-Ingelheim UK (£70,000).
   • Other interests: None.
5. The source of funding for my participation in the work of the Medical and Chemicals Technical Options Committee is personal (or from own NHS hospital endowment account).
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the Medical and Chemicals Technical Options Committee.
9. I understand that this DOI will expire no later than one year after I have signed it.

Name: Jørgen Vestbo
Date: 11th April 2021